This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Validity of Electronic Diary for Monitoring Varicose Veins Symptoms

This study has been completed.
Information provided by (Responsible Party):
BTG International Inc. Identifier:
First received: September 8, 2010
Last updated: March 7, 2013
Last verified: March 2013
The purpose of this study is to contribute to the validation of an electronic daily diary to assess symptoms in patients with varicose veins.

Varicose Veins

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Performance of Daily Electronic Diary to Capture Venous Symptoms Before and After Intervention for Great Saphenous Vein Incompetence

Resource links provided by NLM:

Further study details as provided by BTG International Inc.:

Primary Outcome Measures:
  • To assess the feasibility, variability, validity and sensitivity of patient's varicose vein symptoms using a disease-specific symptom questionnaire, administered as a daily electronic diary in patients undergoing treatment for varicose veins [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • To establish the treatment effect size of foam sclerotherapy treatment [ Time Frame: 8 weeks ]

Enrollment: 45
Study Start Date: November 2010
Study Completion Date: August 2011
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Varicose veins


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Varicose veins

Inclusion Criteria:

  • Sign informed consent and complete study assessments in written English
  • Male or female age 18 to 75
  • Patients having Saphenofemoral Junction (SFJ) incompetence and scheduled to receive foam sclerotherapy treatment for varicose veins in one leg
  • Screening Symptom score of 7 points or more as measured by Question 1 on the modified VEINES-QOL/Sym questionnaire

Exclusion Criteria:

  • Unable to comply with completing a daily diary for a total of 24 days
  • Participation in any other investigational pharmaceutical product, or device study within the 3 months prior to Visit 1
  • Current venous leg ulcer in either leg
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01200199

United Kingdom
Birmingham, United Kingdom, B91 2JL
Sponsors and Collaborators
BTG International Inc.
Study Director: David Wright, MD BTG International Inc.
  More Information

Responsible Party: BTG International Inc. Identifier: NCT01200199     History of Changes
Other Study ID Numbers: RS-002
Study First Received: September 8, 2010
Last Updated: March 7, 2013

Additional relevant MeSH terms:
Varicose Veins
Vascular Diseases
Cardiovascular Diseases processed this record on September 21, 2017